We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$454M
Cap. Flow %
11.2%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$269M
2
SRCL
Stericycle Inc
SRCL
+$141M
3
MRO
Marathon Oil Corporation
MRO
+$108M
4
CHX
ChampionX
CHX
+$103M
5
SPR
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FE icon
426
PUT
FirstEnergy
FE
$27.5B
$27.3K ﹤0.01%
26,000
– –
FAASW
427
DELISTED
DigiAsia Corp Warrant
FAASW
$27.1K ﹤0.01%
135,667
-2,994
-2% -$287
RYTM icon
428
CALL
Rhythm Pharmaceuticals
RYTM
$7.82B
$26K ﹤0.01%
+20,000
New +$958K
MDT icon
429
CALL
Medtronic
MDT
$110B
$25.6K ﹤0.01%
+25,000
New +$2.1M
VRNA
430
CALL
DELISTED
Verona Pharma
VRNA
$25.6K ﹤0.01%
25,000
-15,000
-38% -$369K
PCVX icon
431
PUT
Vaxcyte
PCVX
$8.47B
$25K ﹤0.01%
10,000
– –
GEHC icon
432
CALL
GE HealthCare
GEHC
$32B
$23.5K ﹤0.01%
+20,000
New +$1.68M
USARW
433
DELISTED
USA Rare Earth Inc Warrant
USARW
$22.6K ﹤0.01%
100,248
-3,238
-3% -$552
BDTX icon
434
CALL
Black Diamond Therapeutics
BDTX
$110M
$22.5K ﹤0.01%
300,000
+253,600
+547% +$1.38M
GSK icon
435
PUT
GSK
GSK
$106B
$22.5K ﹤0.01%
+50,000
New +$2.05M
TPH
436
PUT
DELISTED
Tri Pointe Homes
TPH
$22.2K ﹤0.01%
24,700
– –
SNY icon
437
CALL
Sanofi
SNY
$104B
$20.3K ﹤0.01%
15,000
-15,000
-50% -$810K
EWTX icon
438
CALL
Edgewise Therapeutics
EWTX
$4.59B
$20.1K ﹤0.01%
+35,000
New +$696K
AMGN icon
439
CALL
Amgen
AMGN
$219B
$20K ﹤0.01%
+10,000
New +$3.27M
RARE icon
440
CALL
Ultragenyx Pharmaceutical
RARE
$2.52B
$20K ﹤0.01%
25,000
-15,000
-38% -$764K
SNDX icon
441
CALL
Syndax Pharmaceuticals
SNDX
$1.79B
$18.8K ﹤0.01%
+50,000
New +$1.03M
SBGI icon
442
PUT
Sinclair Inc
SBGI
$1.08B
$16.4K ﹤0.01%
109,400
– –
XIFR
443
PUT
XPLR Infrastructure LP
XIFR
$1.09B
$16.3K ﹤0.01%
27,100
– –
ATEC icon
444
CALL
Alphatec Holdings
ATEC
$1.41B
$15.8K ﹤0.01%
70,000
+30,000
+75% +$230K
ESTA icon
445
CALL
Establishment Labs
ESTA
$2.32B
$15K ﹤0.01%
+20,000
New +$870K
IVCAW
446
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
$14.7K ﹤0.01%
209,630
-4,805
-2% -$226
WVE icon
447
CALL
Wave Life Sciences
WVE
$1.19B
$13.8K ﹤0.01%
+50,000
New +$299K
KDKRW
448
Kodiak AI Warrants
KDKRW
$13.6K ﹤0.01%
82,711
-2,672
-3% -$347
RLAY icon
449
CALL
Relay Therapeutics
RLAY
$4.17B
$12.5K ﹤0.01%
+110,000
New +$822K
NAVI icon
450
PUT
Navient
NAVI
$849M
$12.4K ﹤0.01%
16,500
– –
16 17
18
19 20

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $454M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.